Lamotrigine is a medication used for the treatment of epilepsy and stabilizes mood in bipolar disorder. Bipolar disorder is characterized by dramatic shifts in mood, energy, and activity levels affecting a person’s ability to carry out day-to-day tasks. The major factor driving the growth of the global lamotrigine market during the forecast period is the rising prevalence of epilepsy and bipolar disorder.
According to the National Institute of Mental Health (NIMH), bipolar disorder affects approximately 5.7 million adults or about 2.6% of the population age 18 and older every year in the US. Additionally, the median age for bipolar disorder is 25 years, however, the illness can also start in early childhood or as late as 40-50 years of age. Further, as per the World Health Organization (WHO), epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Hence the rising prevalence of epilepsy and bipolar disorder is driving the demand for lamotrigine which in turn is boosting the market growth.
To Request a Sample of our Report on Lamotrigine Market: https://www.omrglobal.com/request-sample/lamotrigine-market
According to the National Institute of Mental Health (NIMH), bipolar disorder affects approximately 5.7 million adults or about 2.6% of the population age 18 and older every year in the US. Additionally, the median age for bipolar disorder is 25 years, however, the illness can also start in early childhood or as late as 40-50 years of age. Further, as per the World Health Organization (WHO), epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Hence the rising prevalence of epilepsy and bipolar disorder is driving the demand for lamotrigine which in turn is boosting the market growth.
Some major players in the market include GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2019, GlaxoSmithKline plc announced the launch of its dispersible tablet formulation of Lamictal (lamotrigine dispersible tablet) drug for the treatment of epilepsy in the Chinese market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape-GlaxoSmithKline plc, among others
A full Report of Lamotrigine Market is Available at: https://www.omrglobal.com/industry-reports/lamotrigine-market
Global Lamotrigine Market Report by Segment
By Type
- Purity98%-99%
- Purity 99%
By Application
- Epilepsy
- Bipolar Disorder
Global Lamotrigine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
